Stockinder’s Daily Market Brief: Corporate Earnings Surprises Clash With Manufacturing Inflation Pressures and Fed Watch

The U.S. stock market is navigating a heavy wave of corporate quarterly results alongside notable macroeconomic updates. The July ISM manufacturing survey revealed a robust expansion in U.S. factory conditions, pushing the primary index to its highest level since May 2022 [6]. However, managers pointed to pricing volatility reminiscent of the Covid era, highlighting persistent inflation pressures [6]. This follows the recent FOMC meeting under Chairman Kevin Warsh, where the committee voted 9 to 3 to maintain the target interest rate [7]. Meanwhile, corporate earnings have sparked varied reactions: Eli Lilly and CVS both beat analyst estimates and raised their guidance on the back of strong product and insurance unit performance [2]. Disney also topped earnings expectations bolstered by its parks and streaming segments [2]. In contrast, Uber issued weaker-than-expected bookings and third-quarter earnings forecasts, and Advanced Micro Devices (AMD) saw its shares sink 8% in premarket trading despite beating expectations [2]. In other corporate updates, Broadridge reported its fourth-quarter and fiscal year 2026 results, noting an 8% increase in recurring revenues, a rise in closed sales to $305 million, and a 12% hike to its annual dividend [5].

The interplay between strong corporate earnings and hot manufacturing data creates a complex environment for market participants. While major names like Eli Lilly, CVS, and Disney demonstrate underlying business strength and consumer resilience, headwinds at companies like Uber and AMD show that market expectations remain exceptionally high [2]. Simultaneously, the jump in factory activity and managers' complaints about pricing volatility suggest that inflation may not be fully vanquished [6]. This adds pressure on Federal Reserve Chairman Kevin Warsh and his colleagues as they weigh potential interest rate hikes for September [6].

Investors are forced to balance sector-specific operational performance against broader macroeconomic risks. Strong performances and raised guidance from healthcare and consumer giants like Eli Lilly and CVS provide confidence in specific operational models, whereas premarket drops like AMD's highlight the penalty for any perceived vulnerability despite headline beats [2]. Furthermore, potential monetary tightening driven by factory-level inflation could alter discount rates and borrowing costs across all sectors [6]. Broadridge's announcement of its 20th consecutive annual dividend increase also highlights how stable, cash-generating financial technology and infrastructure firms continue to reward shareholders [5].

The primary risks facing the market stem from stubborn inflation and the trajectory of monetary policy. If manufacturing pricing volatility continues to push higher, the Federal Reserve under Chairman Warsh may face mounting pressure to implement interest rate hikes in September, which can introduce volatility to equities [6]. Additionally, consumer and transport sectors face execution risks, as evidenced by Uber's softer bookings and earnings forecasts for the third quarter [2].

• Corporate earnings are showing divergence: Eli Lilly, CVS, and Disney surpassed expectations and raised guidance, whereas Uber issued cautious third-quarter forecasts and AMD dropped in premarket trading despite beating estimates [2].
• Broadridge posted strong fiscal year 2026 results with 8% recurring revenue growth and raised its annual dividend by 12% [5].
• The July ISM manufacturing survey hit its highest level since May 2022, but brought renewed inflation warnings that could pressure the Fed regarding September rate decisions [6].

• Eli Lilly and Company
• CVS Health Corporation
• The Walt Disney Company
• Uber Technologies, Inc.
• Advanced Micro Devices, Inc.
• Broadridge Financial Solutions, Inc.

### How did Eli Lilly and CVS perform in their latest earnings reports? Both Eli Lilly and CVS beat analyst estimates and raised their guidance, driven by strong sales of treatments like Zepbound and Mounjaro for Eli Lilly and continued improvement in CVS's insurance unit [2]. ### Why did AMD stock drop despite beating expectations? AMD shares sank 8% in premarket trading despite beating expectations, reflecting market sensitivity to high expectations and specific guidance metrics [2]. ### What did the July ISM manufacturing survey indicate about inflation? The ISM manufacturing survey showed factory activity hitting its highest level since May 2022, but managers noted pricing volatility resembling the Covid era, adding inflation worries that could pressure the Federal Reserve to consider rate hikes in September [6]. ### What were Broadridge's key financial highlights for fiscal year 2026? Broadridge reported an 8% growth in recurring revenues on a reported and constant currency basis, a diluted EPS of $9.60, closed sales of $305 million, and raised its annual dividend by 12% to $4.36 for its 20th consecutive annual increase [5].